Evidence map›Paper›PMID 42419715›Full record

ArticleBone & joint open2026

Weaning in INfant hip DYsplasia (WINDY) study: weaning of brace treatment versus immediate cessation for developmental dysplasia of the hip : study protocol for a randomized multicentre feasibility study.

Joanna Craven, Richard Kirk, Xavier L Griffin, Elizabeth Conroy, Eleanor C Carpenter, Lucy Llewellyn-Stanton, Alexander Aarvold, Daniel C Perry

Abstract read
In one paragraph

Article in Bone & joint open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joanna CravenUniversity of Liverpool, Liverpool, UK.
Richard KirkUniversity of Liverpool, Liverpool, UK.
Xavier L GriffinQueen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK.ORCID 0000-0003-2976-7523
Elizabeth ConroyUniversity of Oxford NDORMS, Oxford, UK.
Eleanor C CarpenterNoah's Ark Children's Hospital for Wales, Cardiff, UK.
Lucy Llewellyn-StantonOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Alexander AarvoldUniversity of Southampton, Southampton, UK.
Daniel C PerryUniversity of Liverpool, Liverpool, UK.ORCID 0000-0001-8420-8252

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Pavlik harness (brace) treatment is the cornerstone of management for infants with developmental dysplasia of the hip (DDH). However, there is wide variation in how the harness is discontinued, with some clinicians stopping immediately and others using gradual reduction ('weaning'), reflecting the absence of high-quality comparative evidence. WINDY (Weaning in INfant hip Dysplasia) is a multicentre randomized feasibility trial comparing a standardized weaning regimen with immediate cessation. The primary aim is to determine whether a definitive multicentre randomized controlled trial (RCT) is feasible. Secondary aims are to assess parental engagement, evaluate the acceptability and measurement properties of the Evaluation Measure for BRACe Experience (EMBRACE), and explore whether routinely collected Smart4NIPE data can be used for trial outcomes. Methods: WINDY is a multicentre, parallel-group feasibility RCT with 1:1 allocation, stratified by site. Infants treated with a Pavlik harness who demonstrate ultrasound normalization (hip centred; α angle ≥ 60°) are eligible. Following consent, infants are randomized to either four weeks of night-time-only harness wear (minimum 10 hours per night) or immediate cessation. Follow-up is 12 weeks and aligned with routine care. Parents complete electronic questionnaires, including EMBRACE, at baseline, two, four, and six weeks post-randomization. Feasibility outcomes include recruitment, proportion randomized, parental engagement, and compliance. EMBRACE measurement properties and the feasibility of using routinely collected national data will also be assessed. Discussion: This study will determine key feasibility parameters for a definitive multicentre RCT comparing harness weaning with immediate cessation in DDH, including recruitment, intervention acceptability, and parent-reported data completion. It will also provide further evaluation of the EMBRACE measure to support family-centred outcomes and assess whether routinely collected Smart4NIPE data can be used for trial outcome capture. As a feasibility study, analyses will be descriptive and will inform the design and delivery of a future definitive trial.

Identifiers

PMID42419715
PMCPMC13345714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.